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Psoriasis is a multifactorial hereditary skin disease. The searches for causative DNA variations have generated
several susceptibility loci, but at present, the gene(s) involved has not been identiﬁed. In this article, we
investigated whether cystatin A, an upregulated gene in psoriatic plaques and located at chromosome 3q21, is the
disease-causing gene at the psoriasis susceptibility locus PSORS5. We also investigated association to a second
gene located in this region, zinc ﬁnger protein 148. The two genes have been sequenced in a small case/control set
in search for SNP markers, followed by family-based association analysis using the transmission disequilibrium
test. We did not detect association with either of the genes.
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Psoriasis vulgaris is a common, inflammatory disease of the
skin. Manifestation is characterized by hyperproliferation
that ultimately leads to red, scaly plaques. The prevalence is
2% to 3% in individuals from Northern Europe and at
present there is no cure and treatment is limited to relieve
symptoms. Psoriasis vulgaris is classified as type I or type II
depending on age of onset of patients (Henseler and
Christophers, 1985; Henseler, 1997). As judged by twin- and
large population-based genetic studies, at least psoriasis
vulgaris type I seems to have a strong genetic component,
but no causative gene product(s) has been identified. At
present it is generally accepted that the disease is both
multifactorial and genetically heterogeneous. Many groups
have pursued the search for causative gene mutations using
linkage analysis in large family cohorts. Several candidate
susceptibility loci have been reported, of which the PSORS1
locus in the HLA region on chromosome 6p is the only
consistently replicated in independent studies (Elder et al,
2001). The PSORS5 locus on chromosome 3q21 (OMIM
604316) was first identified by linkage analysis in a Swedish
family cohort (Enlund et al, 1999; Samuelsson et al, 1999).
Subsequent studies using SNP markers and association
analysis revealed association with a specific 5 SNP-marker
haplotype, extending over 90 kb (Hewett et al, 2002).
Nevertheless, the identification of this haplotype has not,
to the best of our knowledge, led to identification of a
causative DNA variation, despite the intragenic location of
the haplotype in the gene SLC12A8 (Gene Bank No.
NM_024628). Therefore, we have also investigated associa-
tion with the gene zinc finger protein 148 (ZNF148, Gene
Bank No. NM_021964). ZNF148 is located less than 100 kb
from the 50 end of SLC12A8 and the nearest SNP in the
associated haplotype (see Fig 1). ZNF148 has been shown
to be involved in regulation of T cell receptors (Wang et al,
1993). Because the chromosome 3q21 region where
PSORS5 is located has been reported as a susceptibility
locus for other immune-mediated complex diseases such
as rheumatoid arthritis (Cornelis et al, 1998) and atopic
dermatitis (Lee et al, 2000), we speculated that the
overlapping linkage reports might be due to mutations
in the same gene with a function in immune response
regulation.
Another approach in the search for causes of psoriasis is
to study global gene expression in psoriatic plaque and
normal skin (Bowcock et al, 2001; Oestreicher et al, 2001).
Altered gene expression has by such studies been reported
for a number of genes of which some are located at
chromosomal regions identified as harboring psoriasis
susceptibility loci. One example is the cysteine protease
inhibitor cystatin A (CSTA, Gene Bank No. NM_005213)
Figure1
Overview of the PSORS5 region. Only genes and loci described in this
study are indicated. Both SLC12A8 and ZNF148 are transcribed from
the antisense strand. All distances are derived from the UCSC Genome
Bioinformatics Site/Human Genome Browser Gateway (http://genome.
ucsc.edu/).
Abbreviations: CSTA, cystatin A; TDT, transmission dis-
equilibrium test; ZNF148, zinc finger protein 148
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located at the PSORS5 locus (see Fig 1). CSTA has been
shown to have an increased expression level in psoriatic
plaques (Bowcock et al, 2001). We therefore wanted to
investigate whether we could detect association between
CSTA and a Swedish psoriasis family set.
To identify single-nucleotide polymorphisms, coding
regions both of genes and of the promoter region of CSTA
were sequenced in 11 patients carrying the associated
haplotype and 11 healthy blood donors. Identified SNPs
were then genotyped, and preferential transmission of
specific alleles was analyzed by the transmission disequili-
brium test (TDT).
Results and Discussion
Two novel SNPs were found in CSTA and ZNF148,
respectively (see Table I). In CSTA, the first SNP is located
in the promoter region and the second in exon 3. This SNP
leads to an amino acid exchange, threonine ! methionine.
In ZNF148, both SNPs are intronic. We genotyped these
four novel SNPs and one additional SNP located in exon 9
of ZNF148 (dbSNP Accession No. rs 1053738). After
genotyping we analyzed for distorted transmission of
specific alleles using the TDT. No association was detected
for any of the SNPs. We also stratified families according to
transmission of the haplotype associated with affected
children and repeated the TDT analysis. The results
obtained were similar with no association (see Table II).
During the past decade the search for genetic changes
underlying human disease has progressed substantially. By
use of linkage analysis in large family pedigrees, mutations
underlying monogenic diseases have been identified. The
same approach has then been used on common diseases
with a multifactorial origin. Nevertheless, localizing muta-
tions in diseases with complex genetic background has
turned out to be a more difficult task. By combining linkage
and association studies, candidate regions can be de-
creased in size but so far few disease-causing DNA
variations have been identified. This is the case with the
PSORS5 locus on chromosome 3q21. By use of SNP
markers and TDT analysis an associated 5 SNP-marker
haplotype could be identified (Hewett et al, 2002). Although
the haplotype is contained within a single gene, SLC12A8,
all associating SNPs are intronic. This is fully compatible
with a disease-causing function, but to define this,
extensive functional analyses are required.
We have in this study focused on two genes located in a
broader region defined by allelic association to micro-
satellite markers (Enlund et al, 1999). The first gene we
investigated is CSTA. In a global gene expression study,
increased expression of CSTA mRNA was detected in
psoriatic skin compared to healthy skin. This suggests that
CSTA have an important function in skin. Any mutation that
disrupts the normal function might then contribute to the
psoriatic phenotype. The other gene we have investigated is
ZNF148. Our speculation of a role for this gene in psoriasis
etiology is based on the location of the gene at PSORS5
and the function of ZNF148 as a regulator of T cell receptor
expression. We identified novel SNPs in both genes by
sequencing a small population-specific case/control set
and genotyped these in a larger family cohort. No allele
showed any tendency of preferential transmission from
parent to affected child. Similar results were seen after
repeating the analysis with families transmitting the asso-
ciated haplotype only. Although we cannot rule out the
existence of disease-causing mutations in distal regulatory
regions, neither CSTA nor ZNF148 seems to be the genetic
determinant of PSORS5.
In conclusion, we have identified two novel SNPs in
CSTA and two in ZNF148. After association analysis in a
large family set showing linkage and association to the
PSORS5 locus, no preferential transmission of a specific
allele could be detected. It is therefore unlikely that any of
the two genes harbor the genetic cause of psoriasis at the
PSORS5 locus.
Materials and Methods
Family set Patients used for SNP discovery are from the family
cohort used in the original linkage studies. They were all affected
with psoriasis vulgaris and joint involvement and carry the risk
haplotype at the PSORS5 locus previously shown to associate with
psoriasis (Hewett et al, 2002). Healthy individuals recruited among
blood donors in Gothenburg, Sweden, were used as controls.
Families used in the association study were included in the
original localization of PSORS5 (Enlund et al, 1999). All probands
have at least one parent born in the geographically selected region
and both parents were available for genotyping. The collection of
all samples was by informed consent and approved by the local
ethical review committee.
Table I. Sequence of SNaPshot primers used for genotyping
SNP Location Primer sequence Primer length (bp)a Type of mutationb
CSTA SNP1 Promoter, –235 bp 50-CCATGACTCCTGTACTTGCCCAC/T-30 22 NA
CSTA SNP3 119 bp into exon 3 50-(A)36CAAAACAAGGATGACGAGCTGAC/T-30 58 Thr ! Met
ZNF148 SNP2 65 bp 30 of exon 2 50-(A)10TGGATGCCCATGTTACTACACA/G-30 31 NA
ZNF148 SNP3c 179 bp 30 of exon 3 50-(A)12CTTGTGTTAGAGTCTAAAATGACATCATC/T-30 40 NA
ZNF148 SNP9d 119 bp into exon 9 50-(A)29GAAGTACCAGAGGTCACCCCG/A-30 49 No aa exchange
aPoly(A)n-tailsof various lenght were added to primers in order to enable automatic size discrimination.
bNA, not applicable.
cSequence for ZNF148 SNP3 primer is shown in antisense direction as used in the study.
ddbSNP Accession No. rs 1053738.
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